Clinical Trials · NCT00002582
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Institute of Cancer Research, United Kingdom
- Enrollment
- 6,000
- Start date
- Jun 1993
- Locations
- 2 sites, United Kingdom
- Primary endpoint
- Study in Breast Cancer